Search

Search any products, services and so on here.

About 21915 result(s)

Global Measle Vaccine Market Research Report 2024

  • Mar 19, 24
  • ID: 5510
  • Pages: 68
  • Figures: 154
  • Views: 20
  • From $2,900

Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. The global Measle Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % du...


Global PCR Reagent Market Research Report 2024

  • Mar 19, 24
  • ID: 5511
  • Pages: 80
  • Figures: 179
  • Views: 19
  • From $2,900

PCR (Polymerase Chain Reaction) reagents are chemical substances used in the PCR process to amplify and analyze DNA or RNA sequences. The global PCR Reagent market was valued at US$ 3142.3 million in 2023 and is anticipated to reach US$ 4342.9 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at...


Global Prophylactic Human Vaccine Market Research Report 2024

  • Mar 19, 24
  • ID: 5513
  • Pages: 83
  • Figures: 181
  • Views: 21
  • From $2,900

Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on. The global Prophylactic Human Vaccine market was valued at US$ 184 million in 2023 and is anticipated to reach US$ 364.4 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2...


Global Ebola Virus Vaccine Market Research Report 2024

  • Mar 19, 24
  • ID: 5370
  • Pages: 75
  • Figures: 165
  • Views: 19
  • From $2,900

Ebola vaccine refers to the biological products made from the pathogenic microorganisms of Ebola virus and used to inoculate against Ebola virus. The global Ebola Virus Vaccine market was valued at US$ 150 million in 2023 and is anticipated to reach US$ 279.9 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2...


Global Recombinant Therapeutic Protein Market Research Report 2024

  • Mar 19, 24
  • ID: 5371
  • Pages: 93
  • Figures: 210
  • Views: 29
  • From $2,900

Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vectors attached to gene fragments that can be translated into target proteins and then transferred to hos...


Global HER2 Antibody Market Research Report 2024

  • Mar 19, 24
  • ID: 5373
  • Pages: 79
  • Figures: 140
  • Views: 24
  • From $2,900

HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy. The global HER2 Antibody market was valued at US$ 13980 million in 2023 and is anticipated to reach US$ 23040 m...


Global Trastuzumab Market Research Report 2024

  • Mar 19, 24
  • ID: 5374
  • Pages: 77
  • Figures: 180
  • Views: 28
  • From $2,900

Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer th...


Global Pertuzumab Market Research Report 2024

  • Mar 19, 24
  • ID: 5375
  • Pages: 81
  • Figures: 189
  • Views: 27
  • From $2,900

Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it blocks heterodimerization of HER2 with other HER receptors, slowing tumor growth. The global Pertuzumab market was valued at US$ 152 million in 2023 and is anticipated to reach US$ 372.4 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2...


Global Memantine Market Research Report 2024

  • Mar 19, 24
  • ID: 5380
  • Pages: 74
  • Figures: 133
  • Views: 21
  • From $2,900

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. The global Memantine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Memantine is used in the treatment of Alzheimer's disease. The market for Alzheimer's treatments is growing due to an aging population and increas...


Global Cholinergic Drugs Market Research Report 2024

  • Mar 19, 24
  • ID: 5381
  • Pages: 73
  • Figures: 147
  • Views: 22
  • From $2,900

Cholinergic drug, any of various drugs that inhibit, enhance, or mimic the action of the neurotransmitter acetylcholine, the primary transmitter of nerve impulses within the parasympathetic nervous system. The global Cholinergic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global p...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232